Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Switzerland | Healthcare | Pharmaceuticals | CHF 683.50B | 72.4x | CHF 780 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Roche Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 251.51B | 28.4x | -1.02 | CHF 316.20 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
Roche Holding Participation | Switzerland | Healthcare | Pharmaceuticals | CHF 234.48B | 30.5x | -1.02 | CHF 294.30 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.4% Upside | Upgrade to Pro+ | |
Abbott Laboratories | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 203.68B | 17x | 0.13 | CHF 93.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novartis | Switzerland | Healthcare | Pharmaceuticals | CHF 188.96B | 17.9x | -1.01 | CHF 95.74 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.4% Upside | Upgrade to Pro+ | |
Novartis | Switzerland | Healthcare | Pharmaceuticals | CHF 188.96B | 17.9x | -1.01 | CHF 95.72 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lonza Group | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 43.51B | 58x | CHF 601.80 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | ||
Lonza Group | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 43.51B | 58x | CHF 601.80 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.2% Upside | Upgrade to Pro+ | ||
Alcon | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 40.20B | 38.3x | 0.25 | CHF 81.68 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.4% Upside | Upgrade to Pro+ | |
Straumann Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 20.49B | 75.6x | -2.52 | CHF 128.85 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Sandoz | Switzerland | Healthcare | Pharmaceuticals | CHF 19.55B | -2,379.2x | 26.82 | CHF 42.94 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.1% Downside | Upgrade to Pro+ | |
Sonova Holding | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 18.03B | -5.42 | CHF 228.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Zimmer Biomet Holdings Inc | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 17.99B | 22.8x | -2.4 | CHF 109 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sonova H Ag | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 17.79B | 31.5x | -5.42 | CHF 299 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | |
Ypsomed Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 5.13B | 68.9x | 25.93 | CHF 374.50 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
Siegfried Holding Ltd | Switzerland | Healthcare | Pharmaceuticals | CHF 4.56B | 35.2x | -2.44 | CHF 1,056 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.5% Upside | Upgrade to Pro+ | |
BACHEM HOLDING AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 4.34B | 38.1x | 2.54 | CHF 58.10 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.3% Upside | Upgrade to Pro+ | |
Galenica Sante | Switzerland | Healthcare | Pharmaceuticals | CHF 4.08B | 23.1x | -0.71 | CHF 81.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.2% Downside | Upgrade to Pro+ | |
Dottikon Es Holding AG | Switzerland | Healthcare | Pharmaceuticals | CHF 2.97B | 39.4x | -3.16 | CHF 214 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lepu Medical Tech Beijing DRC | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 2.78B | 28.8x | -0.54 | CHF 16.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medacta | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 2.75B | 46.2x | 4.05 | CHF 137.40 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.8% Upside | Upgrade to Pro+ | |
Joincare Pharmaceutical DRC | Switzerland | Healthcare | Pharmaceuticals | CHF 2.70B | 14.7x | 4.97 | CHF 7.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 2.09B | 16.6x | 0.12 | CHF 38.20 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.3% Upside | Upgrade to Pro+ | |
BB Biotech | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 2.08B | 16.9x | 0.12 | CHF 38.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SKAN | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 1.71B | 55.9x | 2.97 | CHF 78.30 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Aevis Victoria | Switzerland | Healthcare | Healthcare Providers & Services | CHF 1.18B | -40.2x | 0.02 | CHF 14.10 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medartis | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 1.03B | 240.4x | 1.54 | CHF 74.30 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
COSMO Pharma | Switzerland | Healthcare | Pharmaceuticals | CHF 1.03B | 15.8x | 0.03 | CHF 64.60 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 43.1% Upside | Upgrade to Pro+ | |
Kuros Biosciences | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 851.44M | -73.6x | -3.07 | CHF 22.55 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PolyPeptide Group AG | Switzerland | Healthcare | Pharmaceuticals | CHF 723.99M | -31.4x | -1.23 | CHF 23.10 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
medmix | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 540.04M | -294.9x | 2.54 | CHF 13.32 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Basilea Pharmaceutica AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 492.80M | -757.4x | 7.38 | CHF 40.85 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IVF Hartmann Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 347.72M | 19.9x | 0.59 | CHF 147 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coltene Holding AG | Switzerland | Healthcare | Healthcare Equipment & Supplies | CHF 325.06M | 26.4x | -0.55 | CHF 54.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.9% Upside | Upgrade to Pro+ | |
Newron Pharmaceuticals | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 214.76M | -11x | 0.68 | CHF 10.72 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Santhera Pharmaceuticals Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 202.03M | 2.7x | 0.02 | CHF 16.02 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Molecular Partners AG | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 169.25M | -2.4x | 0.69 | CHF 4.55 | 7.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Idorsia | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 141.56M | -0.5x | -0.02 | CHF 0.75 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.1% Upside | Upgrade to Pro+ | |
Xlife Sciences | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 119.43M | 11.8x | 0.32 | CHF 20.90 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curatis Holding | Switzerland | Healthcare | Pharmaceuticals | CHF 50.95M | -0.1x | CHF 11.20 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Relief Therapeutics | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 42.01M | -0.4x | CHF 3.42 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SHL Telemedicine | Switzerland | Healthcare | Healthcare Providers & Services | CHF 32.78M | -4.2x | 1.13 | CHF 2.10 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Addex Therapeutics Ltd | Switzerland | Healthcare | Biotechnology & Medical Research | CHF 5.51M | 1x | -0 | CHF 0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Spexis | Switzerland | Healthcare | Pharmaceuticals | CHF 676.64K | -0.2x | CHF 0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |